Rocco Sciarrillo Department of Pediatric Oncology/Hematology VU University Medical Center Biography Publications Institution JoVE Articles Rocco Sciarrillo has not added a biography. If you are Rocco Sciarrillo and would like to personalize this page please email our Author Liaison for assistance. Publications The Association of Aberrant Folylpolyglutamate Synthetase Splicing with Ex Vivo Methotrexate Resistance and Clinical Outcome in Childhood Acute Lymphoblastic Leukemia Haematologica. Jul, 2016 | Pubmed ID: 27036162 NF-κB Drives Acquired Resistance to a Novel Mutant-selective EGFR Inhibitor Oncotarget. Dec, 2015 | Pubmed ID: 26015408 Synergistic Activity of the C-Met and Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells Current Drug Targets. 2014 | Pubmed ID: 25483224 Complete Humanization of the Mouse Immunoglobulin Loci Enables Efficient Therapeutic Antibody Discovery Nature Biotechnology. Apr, 2014 | Pubmed ID: 24633243 N-Hydroxyindole-based Inhibitors of Lactate Dehydrogenase Against Cancer Cell Proliferation European Journal of Medicinal Chemistry. Nov, 2011 | Pubmed ID: 21944286 Met behulp van RNA-sequencing te detecteren Novel Splice varianten Gerelateerd aan Drug Resistance in Rocco Sciarrillo1,2,3, Anna Wojtuszkiewicz1, Irsan E. Kooi4, Valentina E. Gómez3, Ugo Boggi5, Gerrit Jansen6, Gert-Jan Kaspers1,7, Jacqueline Cloos*1, Elisa Giovannetti*3,8,9 1Department of Pediatric Oncology/Hematology, VU University Medical Center, 2Department of Hematology, VU University Medical Center, 3Department of Medical Oncology, VU University Medical Center, 4Department of Clinical Genetics, VU University Medical Center, 5Division of General and Transplant Surgery, Azienda Ospedaliera Universitaria Pisana, Universita’ di Pisa, 6Amsterdam Immunology and Rheumatology Center, VU University Medical Center, 7Princess Máxima Center for Pediatric Oncology, 8Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, 9Institute of Nanoscience and Nanotechnology, CNR-Nano JoVE 54714 Cancer Research
Met behulp van RNA-sequencing te detecteren Novel Splice varianten Gerelateerd aan Drug Resistance in Rocco Sciarrillo1,2,3, Anna Wojtuszkiewicz1, Irsan E. Kooi4, Valentina E. Gómez3, Ugo Boggi5, Gerrit Jansen6, Gert-Jan Kaspers1,7, Jacqueline Cloos*1, Elisa Giovannetti*3,8,9 1Department of Pediatric Oncology/Hematology, VU University Medical Center, 2Department of Hematology, VU University Medical Center, 3Department of Medical Oncology, VU University Medical Center, 4Department of Clinical Genetics, VU University Medical Center, 5Division of General and Transplant Surgery, Azienda Ospedaliera Universitaria Pisana, Universita’ di Pisa, 6Amsterdam Immunology and Rheumatology Center, VU University Medical Center, 7Princess Máxima Center for Pediatric Oncology, 8Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, 9Institute of Nanoscience and Nanotechnology, CNR-Nano JoVE 54714 Cancer Research